| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0098ca1be182f3ed7c0684427781ad6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d603a81ef2ec4e0777d014b858030993
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_626549210fed4cd64a0d4436ed7982d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbe0aac1734be8357ebc747a6e3a4fac |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10 |
| filingDate |
2012-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78445abdd5cb0f3ddacbe5fde731b2b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_715d2a299f0231caf3e4cf0d7425bdb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afd11ae702aac8c129ee85591af288fd |
| publicationDate |
2013-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013030702-A2 |
| titleOfInvention |
Anthelmintic formulations and treatments |
| abstract |
A new method of controlling worm burden in ruminants by using two different injectable anthelmintics at or about the same time to increase the time between treatments and to rely on the animal's immune response. One of the anthelmintics is a long acting formulation capable of providing a sustained release of abamectin or other macrocyclic lactone for 2-14 days, to enable the anthelmintic to remove or kill incoming larvae for a sufficiently long period of time to allow the host to recognise the incoming larvae as foreign, and thus allow the ruminant to mount an immune response against these incoming larvae. The other is a short acting anthelmintic such as levamisole designed to substantially eliminate the initial parasite population of adults, juveniles and larvae. They can be combined into a single injectable formulation with a high percentage of levamisole (preferably over 30% of the formulation w/v) together with about 1% w/v of a macrocyclic lactone such as abamectin, dissolved in glycerol formal. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016377165-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449179-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017108954-A1 |
| priorityDate |
2011-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |